Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer
Authors:
- Sabine EismannSESabine Eismann
- Lisa VetterLVLisa Vetter
- Monika KellerMKMonika Keller
- Thomas BrucknerTBThomas Bruckner
- Michael GolattaMGMichael Golatta
- André HenningsAHAndré Hennings
- Christoph DomschkeCDChristoph Domschke
- Nicola DikowNDNicola Dikow
- Christof SohnCSChristof Sohn
- Jörg HeilJHJörg Heil
- Sarah SchottSSSarah Schott
- 10 June 2016
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 294 (5) , 1011-1018
Abstract
Purpose Advances in genetics and increased public awareness increased the demand for interdisciplinary genetic outpatient consultation (IOGC). Communicating cancer risk is complex, and ideally information transfer should be individualized. Although psychological experiences with genetic testing have been studied in detail, studies on long-term experiences with IOGC and information transfer are lacking. We assessed patients’ understanding and satisfaction with IOGC in families at risk of hereditary breast and ovarian cancer (HBOC) with the aim of informing best clinical practice, improving compliance and informed decision-making. Methods Female counselees referred for IOGC between July 1, 2009 and July 1, 2011 were eligible. Data were collected using a 47-item postal questionnaire to assess sociodemographic, psychological, behavioral parameters. Overall satisfaction and personal usefulness of IOGC were assessed with a five-point, and risk perception with a visual analog scale. Data were analyzed using Spearman rank, Wilcoxon U or Chi-squared test. Results 612 (72 %) of 849 women participated reported being highly satisfied (75 %, n = 430) and declared personal usefulness (73 %, n = 421) on average 3.5 years after IOGC. Women deemed “high risk” assessed their risk of developing BC as significantly higher than non-high-risk counselees (3.2 versus 3.0, p = 0.00484). Risk perception was lower in BRCA1/2 mutation carriers than in women with unclassified variants or no mutation (2.8 versus 3.5 and 3.1, respectively). Conclusion Women with an HBOC background have additional needs to achieve long-term satisfaction after IOGC. Prospective studies are required to optimize care for the increasing number of people who seek genetic consultation, particularly as the complexity of genetics knowledge increases.Keywords
Funding Information
- DGPFG
This publication has 34 references indexed in Scilit:
- Effects of informed consent for individual genome sequencing on relevant knowledgeClinical Genetics, 2012
- Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and GermanyJournal of Community Genetics, 2011
- Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestryHuman Genetics, 2010
- Patient Responses to Genetic Information: Studies of Patients With Hereditary Cancer Syndromes Identify Issues for Use of Genetic Testing in Nephrology PracticeSeminars in Nephrology, 2010
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Exploring the Public Understanding of Basic Genetic ConceptsJournal of Genetic Counseling, 2004
- An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counsellingJournal of Medical Genetics, 2000
- An Update on DNA-Based BRCA1/BRCA2 Genetic Counseling in Hereditary Breast CancerCancer Genetics and Cytogenetics, 1999
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990